Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,061,654
+$455,542 QoQ
Shares Held
16,044
+20.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#1,565
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 14%
None 4%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gryphon Financial Partners LLC holds $43,846,091 across 10 Drug Manufacturers - General names. MRK ranks #5 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
91,741 | $23,085,705 | |
| 2 | LLY |
ELI LILLY & Co
|
6,418 | $7,697,942 | |
| 3 | JNJ |
Johnson & Johnson
|
25,825 | $6,558,775 | |
| 4 | AMGN |
Amgen Inc
|
5,868 | $2,124,920 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
16,044 | $2,061,654 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,540 | $826,263 | |
| 7 | GSK |
GSK plc
|
15,580 | $816,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,157 | $239,526 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,061,654 | 16,044 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,606,112 | 13,352 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,234,173 | 11,725 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $922,810 | 10,995 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $948,335 | 11,980 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,426,824 | 15,896 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,674,645 | 16,834 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,872,830 | 16,492 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,947,621 | 15,732 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,960,380 | 14,857 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,518,647 | 13,930 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $773,050 | 7,509 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $893,926 | 7,747 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $837,182 | 7,869 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $897,140 | 8,086 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $689,131 | 8,002 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $573,458 | 6,290 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $555,969 | 6,776 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $511,264 | 6,671 | Shares | Other | 2022-02-01 | |
| 2021-09-30 | $497,077 | 6,618 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $566,475 | 7,284 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $515,577 | 6,688 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $543,804 | 6,648 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $554,685 | 6,687 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $505,969 | 6,543 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $506,802 | 6,587 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||